Home › Cancro del polmone non a piccole cellule › California › Newport Beach
Studi clinici su Cancro del polmone non a piccole cellule a Newport Beach, CA
14 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Newport Beach e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
In reclutamentoFase 3
- Hoag Hospital Newport Beach, Newport Beach
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
In reclutamentoFase 1
- Research Site, Newport Beach
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
In reclutamentoFase 3
- Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
In reclutamentoFase 1
- Research Site, Newport Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of KK2269 in Adult Participants With Solid Tumors
In reclutamentoFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Hoag Memorial Hospital, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
In reclutamentoFase 1
- Hoag Family Cancer Institute, Newport Beach
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
In reclutamentoFase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
In reclutamentoFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
In reclutamentoFase 3
- Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
In reclutamentoFase 2
- City of Hope at Newport Beach Fashion Island, Newport Beach
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Newport Beach
- Cancro al seno16 studi
- Cancro metastatico10 studi
- BPCO9 studi
- Cancro ovarico9 studi
- Cancro dell'endometrio7 studi
- Cancro ai polmoni7 studi
- Cancro colorettale6 studi
- Cancro alla prostata6 studi
- Cancro al seno triplo negativo6 studi
- Cancro (tutti i tipi)6 studi
- Carcinoma a cellule squamose della testa e del collo5 studi
- Cancro al rene (carcinoma a cellule renali)5 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.